Antonio
Gómez Caamaño
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (5)
2019
-
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672
2018
-
Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 302-314
2016
-
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
Radiotherapy and Oncology, Vol. 121, Núm. 3, pp. 431-439
2015
-
The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy
Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969
2013
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572